Clinical Trial Update: PF-04634817 Renal Impairment Study [Phase 1]

View source ↗

Summary

Phase 1 renal impairment study of PF-04634817 completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Insufficiency

Drugs mentioned

• PF-04634817

Snippet

Sponsor: Pfizer | Conditions: Renal Insufficiency | Phase 1 | Status: COMPLETED | Results posted: 2024-03-01